The U.S. Food and Drug Administration has approved Merck's Keytruda Qlex, a subcutaneous formulation of the cancer drug pembrolizumab, for use in adults across most solid tumor indications. Announced on September 19, 2025, this new injectable version offers a quicker administration time compared to the traditional intravenous method, potentially enhancing patient convenience and access to treatment. The approval highlights efforts to innovate drug delivery in oncology amid growing demands for efficient therapies.

Sweden is set to implement several significant policy updates in September 2025, ranging from tax adjustments to healthcare reforms and public holiday observances, as reported by local sources. These changes are designed to enhance economic stability and social welfare amid ongoing national developments. Residents are advised to review the updates to ensure compliance and take advantage of new benefits.

Oracle has launched a new center dedicated to AI applications in healthcare, focusing on data analysis and patient care improvements. The center aims to integrate AI with medical systems for better outcomes.

Oracle announced a significant push into AI-driven healthcare solutions, integrating advanced analytics for better patient outcomes. This initiative includes new tools for medical data processing. The announcement was made on September 11, 2025.

Pharmacists in the UK are reportedly dispensing medicines at a financial loss, as highlighted in a world news wrapup on September 4, 2025.

The University of Nebraska Medical Center's College of Medicine secured over $7.5 million in new grants and awards for medical research in September 2025. This funding supports various projects aimed at advancing healthcare solutions.